Meloxicam vs Drospirenone: side-by-side comparison
Meloxicam (NSAID (preferential COX-2 inhibitor)) and Drospirenone (Progestogen with anti-mineralocorticoid and anti-androgen activity) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Meloxicam | Drospirenone |
|---|---|---|
| Therapeutic class | NSAID (preferential COX-2 inhibitor) | Progestogen with anti-mineralocorticoid and anti-androgen activity |
| CAS | 71125-38-7 | 67392-87-4 |
| ATC | M01AC06 | G03AA12 |
| Molecular weight | 351.40 g/mol | 366.49 g/mol |
| Brands with this active ingredient | 1 | 2 |
What they share
Meloxicam and Drospirenone share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Meloxicam acts by a different mechanism than Drospirenone, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Meloxicam: Le méloxicam inhibe les cyclo-oxygénases avec une préférence pour la COX-2 aux faibles doses thérapeutiques. Drospirenone: La drospirénone active les récepteurs de la progestérone, ce qui bloque l'ovulation et produit l'effet contraceptif lorsqu'elle est associée à un estrogène.
Indications compared
Meloxicam: Le méloxicam est autorisé chez l'adulte dans le traitement symptomatique de l'arthrose, de la polyarthrite rhumatoïde et de la spondylarthrite ankylosante. Drospirenone: Associée à l'éthinylestradiol, la drospirénone est autorisée en contraception orale combinée, dans le traitement de l'acné modérée chez la femme souhaitant une contraception, et dans le trouble dysphorique prémenstruel.
Safety profile
Meloxicam: Les effets indésirables fréquents comprennent troubles digestifs, œdèmes périphériques, hypertension et céphalées. Drospirenone: Les effets indésirables fréquents comprennent irrégularités menstruelles, tension mammaire, céphalées, variations de l'humeur et nausées, surtout durant les deux à trois premiers cycles.
Questions fréquentes
Is Meloxicam better than Drospirenone? ▾
Meloxicam and Drospirenone are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Meloxicam and Drospirenone be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Meloxicam
Products with Drospirenone
Les informations publiées sur ce site sont fournies à titre documentaire et pédagogique. Elles ne remplacent pas l'avis d'un professionnel de santé qualifié.